Sign in Register

Drug class

Cannabis and Cannabinoid Receptor Agonists

Cannabis and cannabinoid receptor agonists comprise a pharmacological group of natural plant-derived extracts and synthetic compounds that bind to and activate cannabinoid receptors—primarily CB1 and CB2—within the human endocannabinoid system. Read more about Cannabis and Cannabinoid Receptor Agonists

11 drugs in this class 11 manufacturers

Related classes & indications

Antipsychotics, AtypicalCNS, pain & psychiatry · 296 prescription drugs Antidepressant Serotonin-Norepinephrine Reuptake Inh.(SNRIs)CNS, pain & psychiatry · 127 prescription drugs Cancer Chemotherapy-Induced Nausea And VomitingTop indication · 67 prescription drugs

Showing 1–9 of 11 drugs

Sort

DRONABINOL

ANTIEMETIC · ANOREXIA FROM HIV ·+1

ASCEND LABORATO

DRONABINOL

ANTIEMETIC · ANOREXIA FROM HIV ·+1

Lannett Company

DRONABINOL

ANTIEMETIC · ANOREXIA FROM HIV ·+1

RHODES PHARMACE

MARINOL (dronabinol)

ANTIEMETIC · ANOREXIA FROM HIV ·+1

THEPHARMANETWOR

SYNDROS (dronabinol)

ANTIEMETIC · ANOREXIA FROM HIV ·+1

BENUVIA THERAPE

EPIDIOLEX (cannabidiol (CBD))

CANNABIS AND CANNABINOID RECEPTOR AGONISTS · LENNOX-GASTAUT EPILEPSY ·+2

JAZZ PHARMACEUT

DRONABINOL

ANTIEMETIC · ANOREXIA FROM HIV ·+1

Major Pharamceuticals

DRONABINOL

ANTIEMETIC · ANOREXIA FROM HIV ·+1

AVKARE

DRONABINOL

ANTIEMETIC · ANOREXIA FROM HIV ·+1

AHP

Filter & compare in the drug finder → Opens the drug finder with Cannabis and Cannabinoid Receptor Agonists preselected. Add indication or manufacturer filters there.

About Cannabis and Cannabinoid Receptor Agonists.

Cannabis and cannabinoid receptor agonists comprise a pharmacological group of natural plant-derived extracts and synthetic compounds that bind to and activate cannabinoid receptors—primarily CB1 and CB2—within the human endocannabinoid system.

While the exact phrase functions broadly as an administrative and pharmacological category rather than a single standardized FDA class, agents within this spectrum exert their therapeutic effects by modulating neurotransmitter release and central signaling pathways.

In clinical practice, regulatory-approved cannabinoid agonists such as dronabinol and nabilone are indicated for chemotherapy-induced nausea and vomiting as well as anorexia-related weight loss in patients with HIV/AIDS, while related botanical preparations and investigational formulations target neuropathic pain, multiple sclerosis spasticity, and seizure disorders.

nih.gov
Cannabis and cannabinoid receptor agonists comprise a pharmacological group of natural plant-derived extracts and synthetic compounds that bind to and activate cannabinoid receptors—primarily CB1 and CB2—within the human endocannabinoid system
legislativeanalysis.org
Cannabis and cannabinoid receptor agonists comprise a pharmacological group of natural plant-derived extracts and synthetic compounds that bind to and activate cannabinoid receptors—primarily CB1 and CB2—within the human endocannabinoid system
iowa.gov
Cannabis and cannabinoid receptor agonists comprise a pharmacological group of natural plant-derived extracts and synthetic compounds that bind to and activate cannabinoid receptors—primarily CB1 and CB2—within the human endocannabinoid system While the exact phrase functions broadly as an administrative and pharmacological category rather than a single standardized FDA class, agents within this spectrum exert their therapeutic effects by modulating neurotransmitter release and central signaling...
fda.gov
While the exact phrase functions broadly as an administrative and pharmacological category rather than a single standardized FDA class
ancan.org
While the exact phrase functions broadly as an administrative and pharmacological category rather than a single standardized FDA class In clinical practice, regulatory-approved cannabinoid agonists such as dronabinol and nabilone are indicated for chemotherapy-induced nausea and vomiting as well as anorexia-related weight loss in patients with HIV/AIDS, while related botanical preparations and investigational formulations target neuropathic pain, multiple sclerosis spasticity, and seizure disord...
nih.gov
While the exact phrase functions broadly as an administrative and pharmacological category rather than a single standardized FDA class, agents within this spectrum exert their therapeutic effects by modulating neurotransmitter release and central signaling pathways
fda.gov
In clinical practice, regulatory-approved cannabinoid agonists such as dronabinol and nabilone are indicated for chemotherapy-induced nausea and vomiting as well as anorexia-related weight loss in patients with HIV/AIDS, while related botanical preparations and investigational formulations target neuropathic pain, multiple sclerosis spasticity, and seizure disorders
nih.gov
In clinical practice, regulatory-approved cannabinoid agonists such as dronabinol and nabilone are indicated for chemotherapy-induced nausea and vomiting as well as anorexia-related weight loss in patients with HIV/AIDS, while related botanical preparations and investigational formulations target neuropathic pain, multiple sclerosis spasticity, and seizure disorders